Stock Market News2 months Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here’s Why Zacks
AVXL stock soars 95% in three months on positive updates from the development programs of its two clinical candidates, blarcamesine and ANAVEX 3-71.
XAVXL stock soars 95% in three months on positive updates from the development programs of its two clinical candidates, blarcamesine and ANAVEX 3-71.
X